Biotech

All Articles

venBio raises $528M for fifth life scientific researches VC fund

.Professional financial backing company venBio has raised an additional half a billion dollars to ac...

Otsuka pays for $800M for Jnana as well as its clinical-stage PKU drug

.Otsuka Pharmaceutical has picked up Boston-based Jnana Therapies for $800 thousand so the Oriental ...

FibroGen gives up 75% of US personnel as resource flunks 2 more tests

.FibroGen is actually radically restructuring its business, laying off 75% of its U.S. workers as we...

Tracon winds down weeks after injectable PD-L1 prevention stop working

.Tracon Pharmaceuticals has actually made a decision to relax operations full weeks after an injecta...

Ideaya bags possibility on Biocytogen bispecific ADC in $400M package

.Ideaya Biosciences is actually betting $400 thousand in biobucks that a bispecific antibody-drug co...

Takeda takes $140M loss on failed epilepsy medicine, promotes FDA manage

.Our experts currently understand that Takeda is planning to find a pathway to the FDA for epilepsy ...

VBI Vaccinations apply for bankruptcy, looks for resource purchase

.Immunology biotech VBI Vaccines is drifting dangerously close to the climax, along with plannings t...

Celldex anti-cKIT antitoxin lower hives in another stage 2 research study

.It's hard to muscle mass in on a room as reasonable as immunology, yet Celldex Therapies feels that...

Boehringer offers up to $1.3 B for gate prevention biotech

.Boehringer Ingelheim is offering up to $1.3 billion for Nerio Therapeutics and also a preclinical i...

Ventyx's last hope for inflamed med ends in Crohn's failing

.Ventyx Biosciences' Crohn's illness medication performed certainly not help people achieve remissio...